4 ms·
Its a media show... The drug in question only applies to 3000 people, has no patent on it (anyone can manufacture it), is currently the lowest price in its cate
by powertower 10y ago
Its a media show... The drug in question only applies to 3000 people, has no patent on it (anyone can manufacture it), is currently the lowest price in its category, costs $20 if you have insurance, is free if you have no insurance.
They are talking about impoverished women with AIDS in Africa - and the drug company only has a license for the US, the drug itself has nothing to do with AIDS, and is free for half the patients and a $20 co-pay for the other half.
- FireBeyond 10y agoThis is what Shkreli has counted on you believing. The cost is NOT $20. The co-pay is. The amount paid by your insurer is well into the four digits. Your insurer isn't an endowment, it isn't a charity. Notwithstanding a few percent ROI on investing premiums, the only person paying these four digits is you. Or your employer. It's just amortized and spread among a group. "It's not that bad, it's really only $20" is the big trick here. A much higher amount is being billed, and paid, even after negotiation. It's not coming from a magic money fairy.